Healix Infusion Therapy Llc

Community/Retail Pharmacy



  
  1330 Industrial Blvd, Sugar Land
Texas, 77478

 281-295-4343    281-295-4048
Healix Infusion Therapy Llc is a Community/Retail Pharmacy in Sugar Land, Texas. It is located at 1330 Industrial Blvd, Sugar Land and it's customer support contact number is 281-295-4343. The authorized person of Healix Infusion Therapy Llc is Mark Winters who is President of the pharmacy and his contact number is 281-295-4000. Active license number of Healix Infusion Therapy Llc is 20668 for Community/Retail Pharmacy in Texas. Healix Infusion Therapy Llc accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Healix Infusion Therapy Llc is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.


Pharmacy Details:
Healix Infusion Therapy Llc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
Name: Healix Infusion Therapy Llc
Type: Community/Retail Pharmacy
Location:1330 Industrial Blvd, Sugar Land,
Texas, 77478
Phone:281-295-4343
Fax:281-295-4048
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
Name: Mark Winters
Position: President
Contact Number: 281-295-4000
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
NPI Number: 1336399591
NPI Enumeration Date: 24 Sep, 2008
NPI Last Update On: 20 Nov, 2024

Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Healix Infusion Therapy Llc are as mentioned below.
SpecializationLicense NumberStateStatus
Community/Retail Pharmacy 20668TexasPrimary
Home Infusion Therapy Pharmacy Secondary
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
IdentifierTypeStateIssuer
2119642OtherPk
Medicare Enrollment:
Healix Infusion Therapy Llc is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
PAC ID: Enrollment ID: Org NameMedicare Entity Type
5799709101O20100930096296Healix Infusion Therapy IncDME SUPPLIER - PHARMACY
Products Available:
Healix Infusion Therapy Llc has following products available for sale under medicare.
Products:
•  Infusion Pumps & Supplies: External Infusion•  Parenteral Equipment And/or Supplies
•  Parenteral Nutrients
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 2150 Town Square Pl Ste 395,
Sugar Land, Texas
Zip: 77479-1465
Phone Number: 281-295-4261
Fax Number: 281-295-4087
Patients can reach Healix Infusion Therapy Llc at 1330 Industrial Blvd, Sugar Land, Texas or can call on customer care at 281-295-4343.
Comments/ Reviews:
Read all the reviews posted for Healix Infusion Therapy Llc below. You may also share your own experience with Healix Infusion Therapy Llc. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.